Pyrimethamine
Sulfadoxine
Sulfadiazine
Antimalarials
Sulfanilamides
Dapsone
Tetrahydrofolate Dehydrogenase
Folic Acid Antagonists
Proguanil
Drug Combinations
Drug Resistance
Plasmodium falciparum
Chloroquine
Dihydropteroate Synthase
Malaria, Falciparum
Parasitic Sensitivity Tests
Toxoplasmosis, Cerebral
Sulfalene
Atovaquone
Toxoplasma
Malaria
Triazines
Gangliosidoses, GM2
Mefloquine
Artemisinins
Congo
Sesquiterpenes
Drug Therapy, Combination
Naphthoquinones
Cameroon
Chorioretinitis
Inhibitory Concentration 50
Trimethoprim
Toxoplasmosis, Congenital
Pregnancy Complications, Parasitic
Plasmodium vivax
Trimetrexate
Quinine
Gabon
Encephalitis
Toxoplasmosis, Ocular
Primaquine
Sulfinpyrazone
Point Mutation
Somalia
Parasitemia
Thymidylate Synthase
Tanzania
Pneumonia, Pneumocystis
Comoros
Madagascar
Trimethoprim-Sulfamethoxazole Combination
Senegal
Kenya
Central African Republic
Anti-Infective Agents
Quinolines
Angola
Pneumocystis Infections
Mali
Pneumocystis
Hexosaminidase A
AIDS-Related Opportunistic Infections
Gambia
Drug Interactions
Scintillation Counting
Mutation
Polymerase Chain Reaction
Nigeria
Sulfamethoxazole
Malawi
Alleles
Drug Resistance, Microbial
Drug Evaluation
Genotype
Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration. (1/949)
Chinese hamster ovary PyrR100 cells display more than 1000-fold resistance to pyrimethamine (Pyr), a lipophilic antifolate inhibitor of dihydrofolate reductase. PyrR100 cells had wild-type DHFR activity, lost folate exporter activity, and had a 4-fold increased activity of a low pH folic acid transporter. Here we report on the marked alterations identified in PyrR100 cells compared with parental cells: 1) approximately 100-fold decreased folic acid growth requirement; 2) a 25-fold higher glucose growth requirement in Pyr-containing medium; 3) a 2.5- to 4.1-fold increase in folylpolyglutamate synthetase activity; 4) a 3-fold increase in the accumulation of [3H]folic acid and a 3-fold expansion of the intracellular folate pools; 5) a 4-fold increase in the activity of the lysosomal marker beta-hexoseaminidase, suggesting an increased lysosome number/PyrR100 cell; and 6) a small reduction in the steady-state accumulation of [3H]Pyr and no evidence of catabolism or modification of cellular [3H]Pyr. Consequently, PyrR100 cells were markedly resistant to the lipophilic antifolates trimetrexate (40-fold) and AG377 (30-fold) and to the polyglutamatable antifolates 5,10-Dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF) (26-fold) and AG2034 (14-fold). Resistance to these drugs was reversed in PyrR100 cells transferred into folate-depleted medium. In conclusion, these multiple resistance factors collectively result in a prominent increase in folate accumulation, an expansion of the intracellular folylpolyglutamate pool, and abolishment of the cytotoxic activity of polyglutamatable and lipophilic antifolates. The role of increased lysosome number per cell in sequestration of hydrophobic weak base drugs such as Pyr is also discussed as a novel mechanism of drug resistance. (+info)Antimalarial activities of various 9-phenanthrenemethanols with special attention to WR-122,455 and WR-171,669. (2/949)
Pilot appraisals of the activities of 16 specially selected 9-phenanthrenemethanols against acute infections with Plasmodium falciparum in owl monkeys showed that all were more active than the reference compound, WR-33,063. WR-122,455, the most active derivative, and WR-171,669, ranked sixth, were selected for study in human volunteers. To assist this undertaking, appraisals of both compounds in owl monkeys infected with various strains of P. falciparum were expanded. These assessments showed: (i) that WR-122,455 was four times as active as chloroquine against infections with chloroquine-sensitive strains and that WR-171,669 equalled chloroquine in activity; (ii) that these compounds were fully active against infections with strains resistant to chloroquine, pyrimethamine, or quinine, or to all three standard drugs; (iii) that the activity of WR-122,455 was a function of total dose, single doses being as effective as the same amounts delivered in three or seven daily fractions; and (iv) that a single dose of WR-122,455 conferred extended, although only partial, protection against challenges with trophozoites. Complementary experiments in rhesus monkeys inoculated with sporozoites of P. cynomolgi showed that the activity of WR-122,455 was limited to blood schizonts and did not extend to early or late tissue schizonts. These evaluations were compatible with the results of preliminary studies of the activities of WR-122,455 and WR-171,669 in human volunteers. (+info)Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. (3/949)
OBJECTIVES: To examine in pregnant women the relationship between HIV infection and malaria prevalence and to determine, in relation to HIV infection, the effectiveness of sulphadoxine-pyrimethamine in clearing P. falciparum infection. METHOD: Descriptive cross-sectional analysis of P. falciparum prevalence in pregnant women at first antenatal visit and of women at delivery who had received two sulphadoxine-pyrimethamine treatments for malaria. HIV status was assessed in 621 women who attended for antenatal care and for delivery at two rural hospitals in southern Malawi in 1993-94. Information was collected on maternal age, parity and gestational age. Prevalence of P. falciparum was measured at first antenatal visit and delivery. Women were given two routine treatment doses of sulphadoxine-pyrimethamine (SP), at first antenatal visit and between 28 and 34 weeks gestation, conforming to Malawi government policy on antimalarial control during pregnancy. RESULTS: Prevalence of HIV infection was 25.6% and all infections were HIV type-1. In primigravidae malaria prevalence at recruitment was 56.3% in HIV-infected and 36.5% in HIV-uninfected women (P=0.04). The corresponding figures for multigravidae were 23.8% and 11.0%, respectively (P<0.01). HIV-infected primigravidae had increased malaria prevalence at all gestational ages. Peak parasite prevalence occurred earlier in gestation in HIV-infected primigravidae (16-19 weeks if HIV-infected; 20-23 weeks if HIV-uninfected). The relative risk for parasitaemia in HIV-infected compared to HIV-uninfected women was significantly increased in three of five parity groups, including the two highest ones (parity>3), indicating parity-specific immunity to malaria was impaired. Malaria prevalence at delivery remained high in HIV-infected women despite prior routine treatment with sulphadoxine-pyrimethamine in pregnancy There was no significant difference in parasite prevalence at delivery between women who did or did not use sulphadoxine-pyrimethamine. CONCLUSIONS: HIV infection is associated with a significant increase in malaria prevalence in pregnant women of all parities with the effect apparent from early in gestation. Two treatment doses of sulphadoxine-pyrimethamine were inadequate to clear parasitaemia in many women by the time of delivery and this occurred independently of HIV status and despite high sensitivity to SP in this area. There is a need to undertake longitudinal studies to determine the incidence of P. falciparum infection in HIV-infected and uninfected pregnant women and to reassess the frequency and timing of sulphadoxine-pyrimethamine treatment doses in these women. Late pregnancy re-infections with P. falciparum probably explain the high parasite prevalence at delivery following sulphadoxine-pyrimethamine treatment at 28-34 weeks gestation. (+info)Response of falciparum malaria to different antimalarials in Myanmar. (4/949)
The purpose of the study was to ascertain the therapeutic efficacy of different treatments for uncomplicated falciparum malaria in the hospitals in Sagaing, northern and eastern Shan, to facilitate updating the existing national antimalarial drug policy. The proposed 14-day trial for monitoring the efficacy of treatments of uncomplicated falciparum malaria is an efficient method for identifying treatment failure patterns at the intermediate level (township hospital) in the Union of Myanmar. Minimal clinical and parasitological data for days 0-14 were required to classify treatment failure and success. Clinical and parasitiological responses on day 3 and days 4-14 were used as clear examples of early and late treatment failure, respectively. Mefloquine is five times more likely to be effective than chloroquine and sulfadoxine pyrimethamine (S-P), whereas chloroquine and S-P treatments have nearly identical failure patterns. The alarming frequency of clinical and parasitological failure (failure rate > 50%) following chloroquine treatment was reported in Sagaing and following S-P treatment in Sagaing and eastern Shan. (+info)Green fluorescent protein as a marker in Plasmodium berghei transformation. (5/949)
We present a new marker that confers both resistance to pyrimethamine and green fluorescent protein-based fluorescence on the malarial parasite Plasmodium berghei. A single copy of the cassette integrated into the genome is sufficient to direct fluorescence in parasites throughout the life cycle, in both its mosquito and vertebrate hosts. Erythrocyte stages of the parasite that express the marker can be sorted from control parasites by flow cytometry. Pyrimethamine pressure is not necessary for maintaining the cassette in transformed parasites during their sporogonic cycle in mosquitoes, including when it is borne by a plasmid. This tool should thus prove useful in molecular studies of P. berghei, both for generating parasite variants and monitoring their behavior. (+info)Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. (6/949)
This randomized, open-label clinical trial compared a fixed-dose combination of atovaquone and proguanil (n=55) with chloroquine (n=23) or a combination of chloroquine, sulfadoxine, and pyrimethamine (n=32) for treatment of acute falciparum malaria in the Philippines. Patients were hospitalized for 28 days to ensure medication compliance and prevent reinfection. Atovaquone-proguanil produced a significantly higher cure rate (100%) compared with that for chloroquine (30.4%; P<.0001) or chloroquine-sulfadoxine-pyrimethamine (87.5%; P<.05). Treatments did not differ significantly with respect to parasite clearance time (mean: 46.7 h for atovaquone-proguanil, 60.0 h for chloroquine, and 42.8 h for chloroquine-sulfadoxine-pyrimethamine) or fever clearance time (mean, 38.8, 46.8, and 34.5 h, respectively). Adverse events were typical of malaria symptoms; the most frequently reported events were vomiting (18% for atovaquone-proguanil, 17% for chloroquine, and 9% for chloroquine-sulfadoxine-pyrimethamine), abdominal pain (15%, 17%, and 3%, respectively), anorexia (11%, 13%, and 0%, respectively), and headache (6%, 17%, and 3%, respectively). Atovaquone-proguanil was well tolerated and more effective than chloroquine or chloroquine-sulfadoxine-pyrimethamine for treatment of multidrug-resistant falciparum malaria in the Philippines. (+info)In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. (7/949)
There is renewed interest in the rich nickel and cobalt deposits of Pulau Gag, an isolated but malarious island off the northwest coast of Irian Jaya. In preparation for an expanded workforce, an environmental assessment of malaria risk was made, focusing upon malaria prevalence in the small indigenous population, and the in vivo sensitivity of Plasmodium falciparum and P. vivax to chloroquine (CQ) and sulfadoxine/pyrimethamine (S/P), the respective first- and second-line drugs for uncomplicated malaria in Indonesia. During April-June 1997, mildly symptomatic or asymptomatic malaria infections were found in 24% of 456 native residents. Infections by P. falciparum accounted for 60% of the cases. Respective day 28 cure rates for CQ (10 mg base/kg on days 0 and 1; 5 mg/kg on day 2) in children and adults were 14% and 55% (P < 0.005). Type RII and RIII resistance characterized only 5% of the CQ failures. Re-treatment of 36 P. falciparum CQ treatment failures with S/P (25 mg/kg and 1.25 mg/kg, respectively) demonstrated rapid clearance and complete sensitivity during the 28-day follow-up period. More than 97% of the P. vivax malaria cases treated with CQ cleared parasitemia within 48 hr. Three cases of P. vivax malaria recurred between days 21 and 28, but against low drug levels in the blood. The low frequency of RII and RIII P. falciparum resistance to CQ, the complete sensitivity of this species to S/P, and the absence of CQ resistance by P. vivax are in contrast to in vivo and in vitro test results from sites on mainland Irian Jaya. (+info)Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. (8/949)
OBJECTIVE: To summarise the evidence that treating toxoplasmosis in pregnancy reduces the risk of congenital toxoplasma infection and improves infant outcomes. DESIGN: Systematic review of studies comparing at least two concurrent groups of pregnant women with proved or likely acute toxoplasma infection in which treatments were compared with no treatment and outcomes in the children were reported. SUBJECTS: Studies were identified from Medline (1966-97), Pascal (1990-7), Embase (1993-7), and Biological abstracts (1993-5) plus contact with experts in the field, including the European Research Network on Congenital Toxoplasmosis. MAIN OUTCOME MEASURE: Proportion of infected children at 1 year born to infected pregnant women who were or were not treated. RESULTS: Out of 2591 papers identified, nine met the inclusion criteria. There were no randomised comparisons, and control groups were generally not directly comparable with the treatment groups. Congenital infection was common in treated groups. five studies showed that treatment was effective and four that it was not. CONCLUSION: It is unclear whether antenatal treatment in women with presumed toxoplasmosis reduces congenital transmission of Toxoplasma gondii. Screening is expensive, so the effects of treatment and impact of screening programmes need to be evaluated. In countries where screening or treatment is not routine, these technologies should not be introduced outside carefully controlled trials. (+info)Pyrimethamine is an antiparasitic medication that is used to treat certain types of parasitic infections, including malaria caused by Plasmodium falciparum and vivax. It works by inhibiting the growth and reproduction of the parasites in the body. Pyrimethamine is usually given in combination with other antimalarial drugs, such as sulfadoxine-pyrimethamine (Fansidar), to increase its effectiveness and reduce the risk of resistance. It is usually taken orally as a tablet or capsule. Common side effects of pyrimethamine include nausea, vomiting, loss of appetite, and headache. In rare cases, it can cause more serious side effects, such as anemia, liver damage, and allergic reactions. Pyrimethamine is contraindicated in patients with a history of hypersensitivity to the drug or any of its components, as well as in patients with severe liver or kidney disease. It should also be used with caution in pregnant women and breastfeeding mothers, as it may harm the developing fetus or newborn.
Sulfadoxine is an antiparasitic medication that is used to treat a variety of parasitic infections, including malaria, schistosomiasis, and toxoplasmosis. It works by inhibiting the growth and reproduction of parasites in the body. Sulfadoxine is often used in combination with other antiparasitic medications to increase its effectiveness and reduce the risk of resistance. It is usually taken orally in the form of tablets or capsules. Side effects of sulfadoxine may include nausea, vomiting, headache, and dizziness. It is important to follow the instructions of a healthcare provider when taking sulfadoxine and to complete the full course of treatment, even if symptoms improve before the medication is finished.
Sulfadiazine is an antibiotic medication that is used to treat a variety of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It works by inhibiting the growth and reproduction of bacteria in the body. Sulfadiazine is typically administered orally in the form of tablets or capsules. It may also be available as a liquid or as a cream or ointment for topical use. It is important to note that sulfadiazine is not effective against viral infections, such as the flu or common cold. It is also not recommended for use in pregnant women or children under the age of 12, as it may cause harm to these populations. Side effects of sulfadiazine may include nausea, vomiting, diarrhea, headache, and skin rash. In rare cases, it may cause more serious side effects, such as liver damage or blood disorders. It is important to follow the instructions of your healthcare provider and to report any side effects to them immediately.
Sulfanilamides are a group of synthetic antimicrobial drugs that were first developed in the early 20th century. They are also known as sulfa drugs or sulphonamides. Sulfanilamides work by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid, which is essential for their growth and reproduction. Sulfanilamides are commonly used to treat a variety of bacterial infections, including urinary tract infections, bronchitis, and pneumonia. They are also used to treat some skin infections, such as acne and rosacea. However, sulfanilamides are not effective against viral infections or fungal infections. They can also cause side effects, such as nausea, vomiting, and allergic reactions. In some cases, sulfanilamides can cause more serious side effects, such as anemia, liver damage, and blood disorders. Sulfanilamides are no longer the first-line treatment for many bacterial infections, as newer antibiotics have been developed that are more effective and have fewer side effects. However, they are still used in some cases, particularly in developing countries where access to newer antibiotics may be limited.
Dapsone is a medication that is used to treat a variety of infections, including leprosy, dermatitis herpetiformis, and certain types of pneumonia. It is also used to treat certain types of parasitic infections, such as babesiosis and trypanosomiasis. Dapsone works by inhibiting the production of folic acid, which is essential for the growth and reproduction of bacteria and parasites. It is usually taken by mouth, although it can also be given intravenously or topically. Side effects of dapsone may include nausea, vomiting, headache, and anemia. It is important to note that dapsone can cause a severe reaction called Steven-Johnson syndrome, which can be life-threatening. Therefore, it should only be used under the supervision of a healthcare professional.
Tetrahydrofolate dehydrogenase (THD) is an enzyme that plays a crucial role in the metabolism of folate, a B-vitamin that is essential for the synthesis of DNA, RNA, and amino acids. THD catalyzes the conversion of tetrahydrofolate (THF) to dihydrofolate (DHF), which is a key intermediate in the one-carbon transfer reactions that are necessary for the biosynthesis of nucleotides and amino acids. In the medical field, THD deficiency can lead to a range of health problems, including anemia, megaloblastic anemia, and neural tube defects. THD deficiency can be caused by genetic mutations that affect the enzyme's structure or function, or by nutritional deficiencies of folate or its precursors. Treatment for THD deficiency typically involves supplementation with folate or its precursors, as well as management of any underlying medical conditions.
Proguanil is an antimalarial medication that is used to prevent and treat certain types of malaria. It works by inhibiting the growth and reproduction of the Plasmodium parasite, which causes malaria. Proguanil is typically taken as a pill and is often used in combination with other antimalarial medications to increase its effectiveness. It is usually prescribed for travelers to areas where malaria is common, as well as for people who are at high risk of contracting the disease due to their occupation or health status.
Chloroquine is an antimalarial drug that was first discovered in the 1930s. It is a synthetic derivative of quinine, a natural alkaloid found in the bark of the cinchona tree. Chloroquine is used to treat and prevent malaria caused by Plasmodium falciparum, Plasmodium vivax, and other species of Plasmodium. Chloroquine works by inhibiting the growth and reproduction of the Plasmodium parasite within red blood cells. It does this by interfering with the parasite's ability to synthesize heme, a vital component of hemoglobin, which is necessary for the survival of the parasite. Chloroquine is also used to treat autoimmune diseases such as rheumatoid arthritis and lupus. It works by suppressing the immune system's response to foreign substances, reducing inflammation and pain. Chloroquine is available in tablet form and is usually taken orally. It can cause side effects such as nausea, vomiting, headache, and dizziness. Long-term use of chloroquine can also cause retinopathy, a condition that affects the eyes and can lead to vision loss.
Dihydropteroate synthase (DHPS) is an enzyme that plays a crucial role in the biosynthesis of folic acid, a vital nutrient required for the proper functioning of the human body. DHPS catalyzes the conversion of dihydropteroate to 6-hydroxymethyl-7,8-dihydropteroyl-L-glutamate, which is a key intermediate in the synthesis of folic acid. DHPS is a target for the development of antifolate drugs, which are used to treat a variety of infectious and neoplastic diseases. Inhibition of DHPS can lead to a deficiency of folic acid, which can cause a range of symptoms including anemia, megaloblastic anemia, and neural tube defects in developing fetuses. DHPS is found in a variety of organisms, including bacteria, fungi, and plants, and is a target for the development of antibiotics and herbicides. In humans, DHPS is encoded by the DHPS gene, which is located on chromosome 12.
Malaria, Falciparum is a type of malaria caused by the Plasmodium falciparum parasite. It is the most deadly form of malaria, accounting for the majority of malaria-related deaths worldwide. The parasite is transmitted to humans through the bite of infected female Anopheles mosquitoes. Symptoms of falciparum malaria can include fever, chills, headache, muscle and joint pain, nausea, vomiting, and fatigue. In severe cases, the disease can lead to organ failure, coma, and death. Falciparum malaria is typically treated with antimalarial drugs, such as artemisinin-based combination therapies (ACTs). Prevention measures include the use of insecticide-treated bed nets, indoor residual spraying, and antimalarial prophylaxis for travelers to high-risk areas.
Toxoplasmosis, cerebral refers to an infection of the brain caused by the protozoan parasite Toxoplasma gondii. The parasite can infect people and animals, and it is commonly found in cats. When the parasite infects the brain, it can cause inflammation and damage to brain tissue, leading to a range of symptoms such as headaches, fever, confusion, seizures, and changes in behavior or personality. In severe cases, cerebral toxoplasmosis can be life-threatening. It is typically diagnosed through blood tests or imaging studies such as MRI or CT scans. Treatment may involve antiparasitic medications to kill the parasite and reduce inflammation in the brain.
Sulfalene is a medication that is used to treat bacterial infections, including urinary tract infections, skin infections, and respiratory tract infections. It is a type of antibiotic that works by killing or stopping the growth of bacteria. Sulfalene is available in both oral and topical forms, and it is usually taken for a short period of time, typically 7 to 14 days. It is important to follow the instructions of your healthcare provider when taking sulfalene, as taking too much or not taking it at all can lead to antibiotic resistance and other complications.
Atovaquone is an antiprotozoal medication that is used to treat certain types of parasitic infections, including malaria caused by Plasmodium falciparum and P. vivax. It is also used to treat babesiosis, a tick-borne infection caused by the parasite Babesia microti. Atovaquone works by inhibiting the growth and reproduction of the parasites in the body. It is usually taken orally in the form of tablets or capsules.
Malaria is a mosquito-borne infectious disease caused by Plasmodium parasites. It is characterized by fever, chills, headache, muscle aches, and fatigue. In severe cases, it can lead to anemia, respiratory distress, organ failure, and death. Malaria is primarily found in tropical and subtropical regions, particularly in Africa, Asia, and Latin America. There are four main species of Plasmodium that can cause malaria in humans: P. falciparum, P. vivax, P. ovale, and P. malariae. Malaria is preventable and treatable, but,。
Triazines are a class of organic compounds that contain a three-membered nitrogen ring. They are commonly used as herbicides, pesticides, and fungicides. In the medical field, triazines have been studied for their potential use in the treatment of various conditions, including cancer, viral infections, and inflammatory diseases. Some specific examples of triazines that have been studied for medical use include protriptyline, a tricyclic antidepressant, and terbinafine, an antifungal medication. However, it is important to note that the use of triazines in medicine is still in the experimental stage, and more research is needed to fully understand their potential therapeutic benefits and risks.
Gangliosidoses, GM2 is a group of rare genetic disorders that affect the nervous system. These disorders are caused by a deficiency or absence of an enzyme called beta-hexosaminidase A, which is responsible for breaking down a type of fat molecule called ganglioside GM2. As a result, GM2 builds up in the brain and other parts of the body, leading to a range of symptoms and complications. There are two main types of GM2 gangliosidoses: Tay-Sachs disease and Sandhoff disease. Tay-Sachs disease is the more severe form of the disorder and typically affects infants and young children. Symptoms of Tay-Sachs disease can include developmental delays, muscle weakness, vision and hearing loss, and an enlarged liver and spleen. Sandhoff disease is a less severe form of the disorder that typically affects children and adolescents, and symptoms can include developmental delays, muscle weakness, and vision and hearing loss. There is currently no cure for GM2 gangliosidoses, and treatment is focused on managing symptoms and providing supportive care. This may include physical therapy, occupational therapy, and medications to manage seizures and other symptoms. In some cases, bone marrow transplantation may be considered as a potential treatment option.
DNA, Protozoan refers to the genetic material of protozoans, which are single-celled organisms that belong to the kingdom Protista. Protozoans are a diverse group of organisms that can be found in a variety of environments, including soil, water, and the human body. Protozoans have their own unique DNA, which contains the genetic information necessary for their growth, development, and reproduction. This DNA is organized into chromosomes, which are structures that contain the genetic material of an organism. In the medical field, knowledge of the DNA of protozoans is important for understanding the biology of these organisms and for developing treatments for infections caused by protozoans. For example, the DNA of the protozoan Plasmodium, which causes malaria, has been extensively studied in order to develop drugs and vaccines to treat and prevent this disease.
Mefloquine is an antimalarial medication that is used to prevent and treat malaria caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. It is also used to treat certain types of amebiasis, a parasitic infection caused by the amoeba Entamoeba histolytica. Mefloquine is taken orally and works by inhibiting the growth and reproduction of the parasites that cause these infections. It is a member of a class of drugs called quinolines, which are synthetic compounds that have antimalarial activity. Mefloquine is generally well-tolerated, but it can cause side effects such as headache, nausea, dizziness, and insomnia. It is important to take mefloquine exactly as prescribed by a healthcare provider to ensure its effectiveness and to minimize the risk of side effects.
Artemisinins are a group of naturally occurring compounds derived from the plant Artemisia annua, also known as sweet wormwood. They have been used for centuries in traditional medicine to treat a variety of ailments, including fever, malaria, and other infections. In the medical field, artemisinins are primarily used to treat malaria, a life-threatening disease caused by Plasmodium parasites. Artemisinin-based combination therapies (ACTs) are the most effective and widely used treatments for malaria, and they have been credited with saving millions of lives since their introduction in the 1990s. Artemisinins are also being studied for their potential use in treating other diseases, including cancer, bacterial infections, and viral infections such as HIV and Ebola. However, more research is needed to fully understand their mechanisms of action and potential therapeutic applications.
Sesquiterpenes are a class of organic compounds that are derived from terpenes, which are a large and diverse group of natural compounds found in plants, fungi, and some bacteria. Sesquiterpenes are characterized by their molecular formula, which contains 15 carbon atoms arranged in a specific pattern. In the medical field, sesquiterpenes have been studied for their potential therapeutic properties. Some sesquiterpenes have been found to have anti-inflammatory, anti-cancer, and anti-viral effects. For example, some sesquiterpenes have been shown to inhibit the growth of cancer cells and to reduce inflammation in the body. Sesquiterpenes are also used in traditional medicine and are found in a variety of plants, including chamomile, sage, and valerian. Some sesquiterpenes have been used to treat a variety of conditions, including anxiety, insomnia, and digestive disorders. Overall, sesquiterpenes are a promising class of compounds with potential therapeutic applications in the medical field. However, more research is needed to fully understand their properties and potential uses.
Toxoplasmosis, Animal refers to a parasitic infection caused by the protozoan parasite Toxoplasma gondii, which is commonly found in cats and other animals. The infection can be transmitted to humans through contact with infected animal feces, ingestion of undercooked meat containing the parasite, or congenital transmission from an infected mother to her fetus. In animals, the infection can cause a range of clinical signs, including fever, anorexia, and weight loss. However, many animals are asymptomatic carriers of the parasite. In severe cases, the infection can lead to neurological and ocular complications. Treatment for toxoplasmosis in animals typically involves the use of anti-parasitic medications.
Sulfamerazine is an antibiotic medication that is used to treat a variety of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It is a member of the sulfonamide class of antibiotics, which work by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid, an essential nutrient for bacterial growth. Sulfamerazine is available in both oral and topical forms, and is typically prescribed by a healthcare provider to treat specific bacterial infections. It is important to follow the dosing instructions provided by your healthcare provider and to complete the full course of treatment, even if you start to feel better before the medication is finished.
Naphthoquinones are a class of organic compounds that contain a naphthalene ring with a quinone group. They are commonly found in plants and have a wide range of biological activities, including antioxidant, anti-inflammatory, and anticancer properties. In the medical field, naphthoquinones are being studied for their potential use in the treatment of various diseases, such as cancer, cardiovascular disease, and infectious diseases. Some naphthoquinones, such as plumbagin and lawsone, have shown promising results in preclinical studies and are being investigated for their therapeutic potential. However, more research is needed to fully understand the safety and efficacy of naphthoquinones as a treatment for human diseases.
Toxoplasmosis is a parasitic infection caused by the protozoan parasite Toxoplasma gondii. It can affect humans and other animals, including cats, dogs, birds, and rodents. The infection is typically acquired by ingesting food or water contaminated with the parasite, or by coming into contact with infected cat feces. In most healthy individuals, the infection is asymptomatic and clears on its own within a few weeks to a few months. However, in pregnant women, the infection can be transmitted to the developing fetus and cause serious complications such as miscarriage, stillbirth, or birth defects. In people with weakened immune systems, such as those with HIV/AIDS or organ transplant recipients, the infection can cause more severe symptoms and complications. Toxoplasmosis can be diagnosed through blood tests or imaging studies such as ultrasounds or MRIs. Treatment with antiparasitic medications is typically recommended for pregnant women and people with weakened immune systems to prevent complications.
Chorioretinitis is an inflammation of the choroid and retina, which are two layers of tissue at the back of the eye. It can be caused by a variety of factors, including infections, autoimmune diseases, and certain medications. Symptoms of chorioretinitis may include blurred vision, sensitivity to light, and floaters (spots or specks that appear in the field of vision). Treatment for chorioretinitis depends on the underlying cause and may include medications, laser therapy, or surgery.,chorioretinitis。
Trimethoprim is an antibiotic medication that is commonly used to treat bacterial infections, particularly those caused by the bacteria Pneumocystis jirovecii, which can cause pneumonia in people with weakened immune systems, such as those with HIV/AIDS. Trimethoprim is also used to treat urinary tract infections, ear infections, and other types of bacterial infections. It works by inhibiting the growth of bacteria by blocking the production of folic acid, which is essential for the growth and reproduction of bacteria. Trimethoprim is available in both oral and intravenous forms and is usually taken for a period of 7 to 14 days, depending on the type and severity of the infection.
Toxoplasmosis, congenital refers to the transmission of the protozoan parasite Toxoplasma gondii from an infected mother to her fetus during pregnancy. The infection can cause serious health problems in the developing fetus, including brain damage, vision loss, and hearing loss. It is estimated that up to one in every 100 babies born in the United States each year are affected by congenital toxoplasmosis. The infection can be prevented by avoiding exposure to the parasite, such as by washing hands thoroughly after handling raw meat or soil, and by avoiding contact with cat feces. If a woman is infected with T. gondii during pregnancy, her healthcare provider may prescribe medication to reduce the risk of transmission to the fetus.
Pregnancy complications related to parasites refer to health problems that occur during pregnancy as a result of infections caused by parasites. These infections can be transmitted from the mother to the fetus, leading to complications for both the mother and the baby. Some common parasites that can cause pregnancy complications include: 1. Toxoplasmosis: This is caused by the parasite Toxoplasma gondii and can be transmitted to the fetus through the placenta. It can cause miscarriage, stillbirth, or birth defects such as hydrocephalus, brain damage, and vision problems. 2. Malaria: This is caused by the Plasmodium parasite and is transmitted through the bite of an infected mosquito. It can cause anemia, low birth weight, and preterm birth. 3. Chagas disease: This is caused by the Trypanosoma cruzi parasite and is transmitted through the feces of infected triatomine bugs. It can cause miscarriage, stillbirth, and birth defects such as heart problems. 4. Schistosomiasis: This is caused by the Schistosoma parasite and is transmitted through contact with contaminated water. It can cause anemia, low birth weight, and preterm birth. 5. Leishmaniasis: This is caused by the Leishmania parasite and is transmitted through the bite of an infected sandfly. It can cause miscarriage, stillbirth, and birth defects such as hydrocephalus. Prompt diagnosis and treatment of these infections are crucial to prevent complications for both the mother and the baby.
Amodiaquine is an antimalarial medication that is used to treat and prevent malaria caused by Plasmodium falciparum and Plasmodium vivax. It is a member of the 8-aminoquinoline class of antimalarial drugs and works by inhibiting the growth and reproduction of the malaria parasite within red blood cells. Amodiaquine is typically used in combination with other antimalarial drugs, such as artemisinin-based combination therapies (ACTs), to increase its effectiveness and reduce the risk of resistance. It is usually taken orally as a tablet or as a liquid suspension. Common side effects of amodiaquine include nausea, vomiting, headache, dizziness, and skin rash. In rare cases, it can cause more serious side effects, such as liver damage or allergic reactions. Amodiaquine is contraindicated in patients with known hypersensitivity to the drug or to any of its components, as well as in patients with severe liver or kidney disease. It should also be used with caution in patients with a history of epilepsy or other neurological disorders.
Trimetrexate is a medication that is used to treat certain types of infections caused by bacteria, fungi, and parasites. It is a member of a class of drugs called trimethoprim-sulfonamides, which work by inhibiting the growth and reproduction of these microorganisms. Trimetrexate is typically used to treat infections of the skin, respiratory tract, and urinary tract. It may also be used to treat certain types of parasitic infections, such as giardiasis and toxoplasmosis. Trimetrexate is usually taken by mouth in the form of tablets or capsules. The dosage and duration of treatment will depend on the specific infection being treated and the patient's overall health. It is important to follow the instructions provided by your healthcare provider and to complete the full course of treatment, even if you start to feel better before the medication is finished. Like all medications, trimetrexate can cause side effects. Common side effects may include nausea, vomiting, diarrhea, and headache. More serious side effects may include allergic reactions, liver damage, and bone marrow suppression. If you experience any side effects while taking trimetrexate, you should contact your healthcare provider right away.
Quinine is a medication that is used to treat and prevent certain types of malaria. It works by interfering with the growth and reproduction of the parasites that cause malaria. Quinine is also sometimes used to treat leg cramps and to prevent or treat altitude sickness. It is usually taken as an oral tablet or as an intravenous infusion. Quinine can cause side effects such as nausea, vomiting, headache, and ringing in the ears. It can also interact with other medications, so it is important to tell your doctor about all the medications you are taking before starting quinine.
Encephalitis is a medical condition characterized by inflammation of the brain. It can be caused by a variety of factors, including viral or bacterial infections, autoimmune disorders, or exposure to certain toxins. Symptoms of encephalitis can vary widely and may include fever, headache, confusion, seizures, and changes in behavior or personality. In severe cases, encephalitis can lead to long-term neurological damage or even death. Treatment for encephalitis typically involves addressing the underlying cause of the inflammation and providing supportive care to manage symptoms and prevent complications.
Toxoplasmosis, ocular refers to an infection of the eyes caused by the protozoan parasite Toxoplasma gondii. This infection can occur in people who have never had the infection before, as well as in those who have previously been infected with the parasite. The most common way that people become infected with T. gondii is by ingesting the parasite through contaminated food or water, or by coming into contact with infected cat feces. Once the parasite enters the body, it can travel to the eyes and cause inflammation and damage to the retina, which can lead to vision problems or even blindness. Symptoms of ocular toxoplasmosis may include blurred vision, sensitivity to light, and floaters (spots or specks that appear in the field of vision). In some cases, the infection may be asymptomatic and not cause any noticeable symptoms. Treatment for ocular toxoplasmosis typically involves the use of antiparasitic medications, such as pyrimethamine and sulfadiazine, to eliminate the infection and prevent further damage to the eyes. In some cases, surgery may be necessary to repair damage to the retina or to remove scar tissue that has formed as a result of the infection.
Primaquine is an antimalarial medication that is used to treat and prevent certain types of malaria. It is a synthetic derivative of quinine, which is a natural alkaloid found in the bark of the cinchona tree. Primaquine works by inhibiting the growth and reproduction of the Plasmodium parasite, which causes malaria. It is typically used in combination with other antimalarial medications, such as chloroquine or artemisinin-based combination therapies (ACTs), to increase its effectiveness and reduce the risk of resistance. Primaquine is available in both oral and intravenous forms and is usually taken once or twice a day for several weeks. It is generally well-tolerated, but it can cause side effects such as nausea, vomiting, and anemia in some people.
Sulfinpyrazone is a medication that is used to treat gout, a type of arthritis that is caused by the buildup of uric acid crystals in the joints. It works by reducing the amount of uric acid that is produced by the body, which helps to prevent the formation of uric acid crystals and reduce the frequency and severity of gout attacks. It is usually taken in combination with other medications, such as allopurinol, to help lower uric acid levels in the blood.
Protozoan proteins are proteins that are produced by protozoa, which are single-celled organisms that belong to the kingdom Protista. Protozoa are found in a wide range of environments, including soil, water, and the bodies of animals and humans. Protozoan proteins can be of interest in the medical field because some protozoa are pathogenic, meaning they can cause disease in humans and other animals. For example, the protozoan parasite Trypanosoma brucei, which causes African sleeping sickness, produces a number of proteins that are important for its survival and replication within the host organism. Protozoan proteins can also be studied as potential targets for the development of new drugs to treat protozoan infections. For example, researchers are exploring the use of antibodies that target specific protozoan proteins to prevent or treat diseases caused by these organisms. In addition to their potential medical applications, protozoan proteins are also of interest to researchers studying the evolution and biology of these organisms. By studying the proteins produced by protozoa, scientists can gain insights into the genetic and biochemical mechanisms that underlie the biology of these organisms.
Parasitemia is a medical term used to describe the presence of parasites in the blood of an infected individual. It refers to the number of parasites present in a unit volume of blood, usually expressed as the number of parasites per microliter (µL) of blood. Parasitemia is commonly used to monitor the severity of infections caused by parasites such as malaria, leishmaniasis, and trypanosomiasis. The level of parasitemia can also be used to determine the appropriate treatment for the infection. In some cases, high levels of parasitemia can lead to severe symptoms and complications, such as anemia, organ damage, and even death. Therefore, monitoring parasitemia is an important part of the diagnosis and management of parasitic infections.
Thymidylate synthase (TS) is an enzyme that plays a crucial role in DNA synthesis. It catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is a key intermediate in the synthesis of DNA. In the medical field, TS is an important target for cancer chemotherapy. Many anticancer drugs, such as 5-fluorouracil (5-FU) and methotrexate, work by inhibiting TS, thereby blocking DNA synthesis and leading to cell death. Mutations in the TS gene can also lead to inherited disorders such as thymidylate synthase deficiency, which is a rare autosomal recessive disorder characterized by severe combined immunodeficiency and bone marrow failure.
Pneumonia, Pneumocystis is a type of pneumonia caused by the Pneumocystis jirovecii fungus. It is a common infection in people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, and patients undergoing chemotherapy or radiation therapy. The symptoms of Pneumocystis pneumonia can include fever, cough, shortness of breath, chest pain, and fatigue. In severe cases, it can lead to respiratory failure and death if left untreated. Diagnosis of Pneumocystis pneumonia typically involves a combination of chest X-rays, blood tests, and microscopic examination of sputum or bronchoalveolar lavage fluid. Treatment typically involves the use of antifungal medications, such as trimethoprim-sulfamethoxazole or pentamidine.
Trimethoprim-Sulfamethoxazole Combination is a medication that contains two antibiotics: trimethoprim and sulfamethoxazole. It is commonly used to treat bacterial infections such as urinary tract infections, respiratory tract infections, and skin infections. The combination of these two antibiotics provides a broad spectrum of coverage against a variety of bacteria. Trimethoprim inhibits bacterial dihydrofolate reductase, while sulfamethoxazole inhibits bacterial dihydropteroate synthase, both of which are essential for bacterial growth and replication. The medication is usually taken orally in tablet form and is generally well-tolerated, although it may cause side effects such as nausea, vomiting, and allergic reactions.
Quinolines are a class of organic compounds that have a fused ring system consisting of a six-membered aromatic ring and a five-membered heterocyclic ring containing nitrogen. They are structurally related to quinine, which is a well-known antimalarial drug. In the medical field, quinolines have been studied for their potential therapeutic applications in various diseases. Some of the most notable examples include: 1. Antimalarial activity: Quinolines have been used as antimalarial drugs for many years, with quinine being the most widely used. However, resistance to quinine has emerged in some regions, leading to the development of new quinoline-based drugs, such as chloroquine and artemisinin. 2. Antibacterial activity: Some quinolines have been found to have antibacterial activity against a range of gram-positive and gram-negative bacteria. For example, nalidixic acid is a quinoline antibiotic used to treat urinary tract infections caused by certain bacteria. 3. Antiviral activity: Quinolines have also been studied for their potential antiviral activity against viruses such as influenza, HIV, and herpes simplex virus. 4. Antifungal activity: Some quinolines have been found to have antifungal activity against Candida species, which are common causes of fungal infections in humans. Overall, quinolines have a diverse range of potential therapeutic applications in the medical field, and ongoing research is exploring their use in the treatment of various diseases.
Pneumocystis infections are a group of respiratory infections caused by the fungus Pneumocystis jirovecii. These infections are most commonly seen in people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, and patients undergoing chemotherapy or radiation therapy. Pneumocystis infections can range from mild to severe and can cause symptoms such as cough, shortness of breath, fever, and fatigue. In severe cases, the infection can lead to pneumonia, which can be life-threatening. Diagnosis of Pneumocystis infections typically involves a combination of clinical symptoms, imaging studies, and laboratory tests. Treatment typically involves the use of antifungal medications, such as trimethoprim-sulfamethoxazole or pentamidine. Pneumocystis infections are a significant public health concern, particularly in populations with weakened immune systems. Efforts to prevent the spread of the fungus include vaccination, infection control measures, and the use of antifungal prophylaxis in high-risk populations.
Hexosaminidase A is an enzyme that plays a crucial role in the breakdown of certain complex sugars, known as gangliosides, which are found in the brain and other parts of the nervous system. Gangliosides are important for the proper functioning of nerve cells, and hexosaminidase A helps to break them down into simpler sugars that can be used by the body for energy. Mutations in the gene that codes for hexosaminidase A can lead to a group of inherited disorders known as lysosomal storage diseases, which are characterized by the accumulation of undigested gangliosides in the body's cells. The most common of these disorders is Tay-Sachs disease, which affects primarily infants and young children and is caused by a deficiency in hexosaminidase A. Other lysosomal storage diseases that are caused by mutations in the hexosaminidase A gene include Sandhoff disease and GM2 gangliosidosis. Hexosaminidase A is also important for the breakdown of certain types of bacteria and viruses, and it has been studied as a potential target for the development of new treatments for infectious diseases.
AIDS-Related Opportunistic Infections (AROIs) are infections that occur when the immune system is weakened due to HIV/AIDS. The immune system is responsible for fighting off infections and diseases, but when it is weakened, it is unable to effectively fight off these infections. As a result, people with HIV/AIDS are more susceptible to a variety of infections that would not normally cause illness in people with a healthy immune system. These infections are called opportunistic infections because they take advantage of the weakened immune system to cause illness. Some common AROIs include pneumonia, tuberculosis, and yeast infections. Treatment for AROIs typically involves antiretroviral therapy (ART) to control the HIV infection and medications to treat the specific infection.
Clindamycin is an antibiotic medication that is used to treat a variety of bacterial infections. It is a lincosamide antibiotic that works by stopping the growth of bacteria. Clindamycin is often used to treat infections of the skin, respiratory tract, and reproductive system, as well as certain types of bacterial infections that are resistant to other antibiotics. It is usually taken by mouth or given by injection, depending on the type and severity of the infection being treated. Clindamycin can cause side effects such as nausea, diarrhea, and stomach pain, and it may interact with other medications, so it is important to follow your healthcare provider's instructions carefully when taking this medication.
Sulfamethoxazole is an antibiotic medication that is used to treat a variety of bacterial infections, including urinary tract infections, respiratory infections, skin infections, and ear infections. It is a member of the sulfonamide class of antibiotics, which work by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid, an essential nutrient for bacterial growth. Sulfamethoxazole is typically used in combination with another antibiotic, such as trimethoprim, to increase its effectiveness and reduce the risk of resistance. It is usually taken orally in the form of tablets or capsules, and the dosage and duration of treatment will depend on the specific infection being treated and the patient's medical condition. It is important to note that sulfamethoxazole can cause side effects, including nausea, vomiting, diarrhea, headache, and allergic reactions. It may also interact with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting treatment with sulfamethoxazole.
Fluorenes are a class of organic compounds that contain a benzene ring fused to a fluorine atom. They are typically colorless or yellowish solids with a characteristic odor. In the medical field, fluorenes have been studied for their potential use as drugs and as imaging agents. For example, some fluorenes have been shown to have anti-inflammatory and anti-cancer properties, while others have been used as fluorescent probes to visualize specific cellular processes. However, more research is needed to fully understand the potential therapeutic applications of fluorenes.
Pyrimethamine
Sydney Grammar School
Alice Motion
Lemelson-MIT Prize
Gertrude B. Elion
Vyera Pharmaceuticals
Ethyl propionate
Equine protozoal myeloencephalitis
Antimalarial medication
Roche
Dihydrofolate reductase
Quartan fever
2012 Pakistan fake medicine crisis
Amodiaquine
Biohybrid microswimmer
Antifolate
Leucocytozoon caulleryi
Toxoplasmosis
Mass drug administration
David Morley (paediatrician)
Malaria
Sulfadoxine
Toxoplasmic chorioretinitis
WHO Model List of Essential Medicines
WHO Model List of Essential Medicines for Children
Tay-Sachs disease
Encephalitis
HEXB
Ion trapping
HAND1
Pyrimethamine | Hackaday
Figure 2 - Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and...
Guilin's pyrimethamine/sulfadoxine dispersible tablet prequalified | WHO - Prequalification of Medical Products (IVDs,...
Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling...
Results of search for 'su:{Pyrimethamine.}'
›
WHO HQ Library catalog
Pyrimethamine Archives | SpacePtc
CDC - Malaria - Glossary
Co-trimoxazole Injection: MedlinePlus Drug Information
Ocular Toxoplasmosis: Overview, Pathogenesis, Congenital Versus Acquired Ocular Toxoplasmosis
Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine...
Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk...
Prophylaxis Against Pneumocystis carinii Pneumonia for HIV-Infected
Cleocin (clindamycin) dosing, indications, interactions, adverse effects, and more
Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar -...
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub...
Apo-Piroxicam - Uses, Side Effects, Interactions - MedBroadcast.com
Gantrisin (Acetyl Sulfisoxazole Pediatric Suspension): Uses, Dosage, Side Effects, Interactions, Warning
Characterization of "Yaa Chud" Medicine on the Thailand-Myanmar Border: Selecting for Drug-resistant Malaria and Threatening...
WHOCC - ATC/DDD alterations 2021
Dapsone dosing, indications, interactions, adverse effects, and more
Cell biology | PLOS ONE
Atovaquone Monograph for Professionals - Drugs.com
Congenital Toxoplasmosis - Pediatrics - MSD Manual Professional Edition
MedlinePlus - Search Results for: Triamterene
Sulfadoxine-pyrimethamine6
- Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended to prevent the adverse consequences of MiP. (rti.org)
- Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine-pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon Region. (bvsalud.org)
- Plasmodium falciparum resistance to intermittent preventive treatment with sulfadoxine - pyrimethamine (IPTp-SP) continues to spread throughout sub-Saharan Africa . (bvsalud.org)
- The approach has led to a dramatic increase in pregnant women receiving a third dose of intermittent preventive treatment (IPTp3) using sulfadoxine-pyrimethamine, as recommended by the World Health Organization. (jhpiego.org)
- Chloroquine, quinine and sulfadoxine/pyrimethamine were the most available and prescribed antimalarial drugs in all 60 pharmacies (government and private) in the city. (who.int)
- andthatarerelatedtolocalvariables differentpharmacologicalformulations Sulfadoxine/pyrimethamine,halofan- inourcountry[ 2 ].Therearecertain andstrengthsofantimalarialdrugs.This trineandartemetherwereprescribed prescribingpatternsthatmighthave wasdonebydirectinterviewwiththe in 4.8%, 2.4% and 2.4% of prescrip- directinfluenceontheeffectiveness pharmacistsandtheirassistants. (who.int)
Sulphadoxine-pyrimethamine1
- Development of resistance to inexpensive treatment drugs such as chloroquine in the 1950s and 1960s and sulphadoxine-pyrimethamine in the 1970s led to the reversal of decades worth of gains achieved by malaria control programs. (cdc.gov)
Leucovorin3
- used alone or in conjunction with pyrimethamine (and leucovorin) for primary PCP prophylaxis in HIV-infected adults and adolescents. (drugs.com)
- pyrimethamine (and leucovorin) in conjunction with clindamycin is preferred alternative in those who cannot tolerate or do not respond to regimen of choice. (drugs.com)
- Atovaquone in conjunction with pyrimethamine (and leucovorin), atovaquone in conjunction with sulfadiazine, or atovaquone alone are alternative regimens for treatment of toxoplasmosis †[off-label] in HIV-infected adults and adolescents when regimen of choice and preferred alternative cannot be used. (drugs.com)
Artesunate2
- The purpose of this study is to determine the comparative efficacy of artesunate plus sulfamethoxypyrazine-pyrimethamine versus Praziquantel in the treatment of school children infected with S.mansoni in western Kenya. (drugpatentwatch.com)
- Our product range includes a wide range of zestril lisinopril tablets, artesunate pyrimethamine sulfadoxine combikit, primaquine phosphate 7.5 mg, hcqs 400 tablet hydroxychloroquine tablet, quinine sulphate 300 mg and premaquine 7.5 mg tablets. (onlinepharmacysolution.com)
Daraprim2
- This was the case with Pyrimethamine (sold as Daraprim), which is used to treat toxoplasmosis and malaria, among other users. (hackaday.com)
- Pyrimethamine, more commonly known as Daraprim, is a drug that is frequently prescribed for the treatment of protozoal infections and malaria around the world. (brown.edu)
Combination1
- Combination product containing sulfadoxine 500 mg and 25 mg pyrimethamine. (medscape.com)
Search1
- Results of search for 'su:{Pyrimethamine. (who.int)
Therapy1
- Pyrimethamine therapy, perhaps shortened, may rapidly decrease size of spleen. (medscape.com)
Alternative1
- Pyrimethamine may be an alternative. (medscape.com)
Sulfadoxine23
- Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998. (ajtmh.org)
- High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. (ajtmh.org)
- Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. (ajtmh.org)
- In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment. (ajtmh.org)
- Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. (nih.gov)
- Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine. (nih.gov)
- Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. (nih.gov)
- The risks of pyrimethamine-sulfadoxine combination in the prenatal treatment of toxoplasmosis]. (nih.gov)
- The combination of sulfadoxine and pyrimethamine is used in the treatment and prophylaxis of chloroquine resistant strains of malaria and the treatment of toxoplasmosis. (nih.gov)
- Sulfadoxine-pyrimethamine has been linked with rare cases of idiosyncratic liver injury which resembles the hepatotoxicity associated with sulfonamides. (nih.gov)
- Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand. (nih.gov)
- Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. (nih.gov)
- Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More than Just an Antimalarial? (cdc.gov)
- For monitoring efficacy of sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy, data obtained from studies of children seemed inadequate. (cdc.gov)
- High prevalence of triple and quadruple mutants in the dihydropteroate synthase and dihydrofolate reductase genes of Plasmodium falciparum parasites contrasts with the efficacy of sulfadoxine/pyrimethamine in reducing low birthweights and placental infection rates. (cdc.gov)
- Until recently, prevention consisted of weekly chemoprophylaxis with either chloroquine or sulfadoxine/pyrimethamine. (cdc.gov)
- Because of poor patient compliance with prophylaxis and increasing resistance of parasite strains to chloroquine, administration of intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine/pyrimethamine is now recommended for all pregnant women living in areas with stable malaria transmission ( 3 ). (cdc.gov)
- Administration of three courses of sulfadoxine/pyrimethamine (SP) as intermittent preventive treatment (IPTi) to infants when they receive EPI vaccines reduced the incidence of malaria and anaemia in infants in an area with low SP resistance, low transmission pressure and high bednet use. (druglib.com)
- C - Risk of P. falciparum malaria, in combination with reported chloroquine and sulfadoxine-pyrimethamine resistance. (tripprep.com)
- Sulfadoxine-pyrimethamine has been widely used as first-line therapy for uncomplicated malaria throughout sub-Saharan Africa. (elsevierpure.com)
- Dispersible sulfadoxine-pyrimethamine and amodiaquine and matching placebos ended up donated by Guilin Pharmaceutical. (besthealthideas.com)
- Small children in the chemoprevention-by yourself group and the mixture team acquired four courses of sulfadoxine-pyrimethamine and amodiaquine at every month intervals each yr small children in the vaccine-by yourself group gained four courses of sulfadoxine-pyrimethamine and amodiaquine placebos on that very same plan. (besthealthideas.com)
- Administration of each dose of sulfadoxine-pyrimethamine and amodiaquine or placebo was specifically noticed by demo staff at distribution factors in trial villages. (besthealthideas.com)
Daraprim4
- The US Food and Drug Administration (FDA) has approved the first generic version of the antiparasitic drug Daraprim (pyrimethamine) for the treatment of toxoplasmosis when used with a sulfonamide. (medscape.com)
- Cite this: FDA OKs First Generic of Daraprim (Pyrimethamine) Tablets - Medscape - Mar 02, 2020. (medscape.com)
- Pyrimethamine (Daraprim) Pyrimethamine is used to treat parasite infections. (nih.gov)
- Folic acid might decrease the effectiveness of pyrimethamine (Daraprim) for treating parasite infections. (nutrawiki.org)
Contraindicated in patients with2
- Use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. (nih.gov)
- Pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or with documented megaloblastic anemia due to folate deficiency. (medscape.com)
Folic acid2
- Pyrimethamine is a folic acid antagonist and the rationale for its therapeutic action is based on the differential requirement between host and parasite for nucleic acid precursors involved in growth. (nih.gov)
- dihydropteroate synthase (sulphadoxine) and dihydrofolate reductase (pyrimethamine) both of which are involved in the production of folic acid in the parasite cells. (com.ng)
Malaria2
- Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. (ajtmh.org)
- Studies on Genetic Mutations in Plasmodium Falciparum Strains Associated With 4- Aminoquinolines (Chloroquine) and Pyrimethamine Sulphadoxine (Fansidar) Resistance in Ghanaian Malaria Patients. (edu.gh)
Toxoplasmosis7
- Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. (nih.gov)
- The dosage of pyrimethamine required for the treatment of toxoplasmosis has a narrow therapeutic window. (nih.gov)
- a 51-year-old female who developed chronic granulocytic leukemia after taking pyrimethamine for 2 years for toxoplasmosis 3 and a 56-year-old patient who developed reticulum cell sarcoma after 14 months of pyrimethamine for toxoplasmosis. (nih.gov)
- A small "starting" dose for toxoplasmosis is recommended in patients with convulsive disorders to avoid the potential nervous system toxicity of pyrimethamine. (nih.gov)
- With doses of pyrimethamine used to treat toxoplasmosis, anorexia and vomiting may also occur. (medscape.com)
- of infants with congenital toxoplasmosis most often includes pyrimethamine , sulfadiazine, and leucovorin for one year. (nih.gov)
- As an alternative to sulfonamides, clindamycin may be beneficial when used with pyrimethamine in acute treatment of CNS toxoplasmosis in patients with AIDS. (medscape.com)
Sulfadiazine2
- Pyrimethamine and sulfadiazine are synergistic against Toxoplasma species. (medscape.com)
- It is also used in patients who are unable to tolerate pyrimethamine and sulfadiazine due to side effects. (medscape.com)
Becoming pregnant1
- Women of childbearing potential who are taking pyrimethamine should be warned against becoming pregnant. (nih.gov)
Toxicity1
- Genetic Toxicity Evaluation of Pyrimethamine in Salmonella/E.coli Mutagenicity Test or Ames Test. (nih.gov)
Doses1
- Pyrimethamine has been reported to produce a significant increase in the number of lung tumors in mice when given intraperitoneally at doses of 25 mg/kg. (nih.gov)
Indications1
- Patients should also be warned that the appearance of sore throat, pallor, purpura, or glossitis may be early indications of serious disorders which require treatment with pyrimethamine to be stopped and medical treatment to be sought. (nih.gov)
Infants1
- Pyrimethamine should be kept out of the reach of infants and children as they are extremely susceptible to adverse effects from an overdose. (nih.gov)
Antiparasitic1
- Pyrimethamine is an antiparasitic compound available in tablet form for oral administration. (nih.gov)
Phenytoin1
- Pyrimethamine should be used with caution in patients with impaired renal or hepatic function or in patients with possible folate deficiency, such as individuals with malabsorption syndrome, alcoholism, or pregnancy, and those receiving therapy, such as phenytoin, affecting folate levels (see Pregnancy subsection). (nih.gov)
Toxoplasma1
- The action of pyrimethamine against Toxoplasma gondii is greatly enhanced when used in conjunction with sulfonamides. (nih.gov)
Pregnancy1
- Pancytopenia in a patient given pyrimethamine and sulphamethoxidiazine during pregnancy. (nih.gov)
Patients2
Levels2
- Pyrimethamine is well absorbed with peak levels occurring between 2 to 6 hours following administration. (nih.gov)
- pyrimethamine increases levels of eliglustat by affecting hepatic enzyme CYP2D6 metabolism. (medscape.com)
Reach of children1
- Pyrimethamine should be stored out of the reach of children, the FDA advises. (medscape.com)
Effect1
- pyrimethamine will increase the level or effect of erdafitinib by affecting hepatic enzyme CYP2C9/10 metabolism. (medscape.com)
Human1
- Pyrimethamine is 87% bound to human plasma proteins. (nih.gov)